Patterns of lung function abnormalities in smokers as possible manifestation of "early" COPD phenotypes

A. Corsico, L. Carrozzi, F. Pistelli, E. Gini, F. Albicini, A. Grosso, F. Aquilini, R. Niniano, F. Imberti, E. Tsana Tegomo, M. Agnesi, A. Foresi, I. Cerveri (Pisa, Sesto San Giovanni, Italy)

Source: Annual Congress 2012 - New issues in pulmonary function
Session: New issues in pulmonary function
Session type: Thematic Poster Session
Number: 859
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Corsico, L. Carrozzi, F. Pistelli, E. Gini, F. Albicini, A. Grosso, F. Aquilini, R. Niniano, F. Imberti, E. Tsana Tegomo, M. Agnesi, A. Foresi, I. Cerveri (Pisa, Sesto San Giovanni, Italy). Patterns of lung function abnormalities in smokers as possible manifestation of "early" COPD phenotypes. Eur Respir J 2012; 40: Suppl. 56, 859

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effectiveness of a panel of sputum markers in smokers with and without COPD to detect pulmonary progression towards functional impairment
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020


Genetic features of decrease in lung function in various forms of a chronic bronchitis
Source: Eur Respir J 2005; 26: Suppl. 49, 518s
Year: 2005

Prevalence of lung function abnormalities in smokers with ischemic heart disease
Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Year: 2019

Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011

Morphological markers of resistance bronchial mucosa of smokers to the development of COPD
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016

Predictors of lung function deterioration in COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016


The correlation between lung sound distribution and pulmonary function in COPD patients is influenced by emphysematous lesions
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014

Effect of smoking on lung functions in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 157s
Year: 2005

Lung function decline in relation to alpha-1-antitrypsin phenotypes in severe asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 479s
Year: 2003

The relationship of exacerbations and lung function decline to radiologic characteristics in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 512s
Year: 2005

Who are they? Characteristics of smokers with previously undetected COPD
Source: Annual Congress 2006 - COPD – the challenges for primary care
Year: 2006


Impairment of lung function in asymptomatic smokers
Source: Eur Respir J 2005; 26: Suppl. 49, 152s
Year: 2005

Prenosological diagnosis of respiratory function abnormalities in smokers
Source: Annual Congress 2012 - Tobacco comorbidity
Year: 2012

The "rapid decliner" as a COPD phenotype associated with predominant emphysema
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011

Features of the bronchial mucosa in heavy smokers with and without chronic obstructive pulmonary disease
Source: International Congress 2015 – COPD: interesting notes
Year: 2015


Relationship between lung function disorders and condition of cardiovascular system in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 422s
Year: 2003

Lung function indices versus symptoms for monitoring the course of the disease in patients with COPD
Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates
Year: 2008

The coexistence of asthma and COPD: risk factors, clinical history and lung function trajectories
Source: Eur Respir J, 58 (5) 2004656; 10.1183/13993003.04656-2020
Year: 2021



Impact of a single chronic obstructive pulmonary disease (COPD) exacerbation on lung function decline: Analysis of UPLIFT®
Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments
Year: 2012

Predictors of progression and risk of unfavorable outcome of chronic obstructive pulmonary disease
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015